FGFR1 amplification or overexpression and hormonal resistance in luminal breast cancer: rationale for a triple blockade of ER, CDK4/6, and FGFR1

  1. Mouron, S.
  2. Manso, L.
  3. Caleiras, E.
  4. Rodriguez-Peralto, J.L.
  5. Rueda, O.M.
  6. Caldas, C.
  7. Colomer, R.
  8. Quintela-Fandino, M.
  9. Bueno, M.J.
Journal:
Breast Cancer Research

ISSN: 1465-542X,  1465-5411

Year of publication: 2021

Volume: 23

Issue: 1

Type: Article

DOI: 10.1186/S13058-021-01398-8 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus